Total Payments
$912.34
2024 Payments
$29.61
Companies
9
Transactions
18
Medicare Patients
1,780
Medicare Billing
$863,350
Payment Breakdown by Category
Food & Beverage$912.34 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $912.34 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $268.22 | 3 | $0 (2019) |
| Genentech USA, Inc. | $147.73 | 3 | $0 (2022) |
| Genentech, Inc. | $126.33 | 1 | $0 (2023) |
| Spark Therapeutics, Inc. | $124.99 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $94.00 | 1 | $0 (2019) |
| Alimera Sciences, Inc. | $93.68 | 6 | $0 (2019) |
| ABBVIE INC. | $29.61 | 1 | $0 (2024) |
| Biogen, Inc. | $15.28 | 1 | $0 (2022) |
| Apellis Pharmaceuticals, Inc. | $12.50 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.61 | 1 | ABBVIE INC. ($29.61) |
| 2023 | $126.33 | 1 | Genentech, Inc. ($126.33) |
| 2022 | $146.81 | 3 | Genentech USA, Inc. ($119.03) |
| 2021 | $16.18 | 1 | Genentech USA, Inc. ($16.18) |
| 2019 | $447.05 | 10 | Spark Therapeutics, Inc. ($124.99) |
| 2018 | $146.36 | 2 | Regeneron Healthcare Solutions, Inc. ($146.36) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: EYE CARE | ||||||
| 11/03/2023 | Genentech, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $126.33 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/02/2022 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| 10/25/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $15.28 | General |
| 05/11/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $119.03 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/21/2021 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Ophthalmology | ||||||
| 11/13/2019 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Ophthalmology | ||||||
| 11/07/2019 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $10.83 | General |
| Category: Ophthalmology | ||||||
| 11/07/2019 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $10.83 | General |
| Category: Ophthalmology | ||||||
| 10/23/2019 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $13.02 | General |
| Category: Ophthalmology | ||||||
| 10/23/2019 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $13.02 | General |
| Category: Ophthalmology | ||||||
| 09/19/2019 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $22.99 | General |
| Category: Ophthalmology | ||||||
| 09/19/2019 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $22.99 | General |
| Category: Ophthalmology | ||||||
| 08/15/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $94.00 | General |
| 07/26/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $121.86 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/06/2019 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: OCULAR | ||||||
| 11/02/2018 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $123.31 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/10/2018 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 536 | 1,854 | $1.2M | $388,886 |
| 2022 | 10 | 617 | 1,589 | $846,300 | $295,203 |
| 2021 | 9 | 374 | 815 | $409,950 | $147,041 |
| 2020 | 6 | 253 | 510 | $98,300 | $32,220 |
Total Patients
1,780
Total Services
4,768
Medicare Billing
$863,350
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 29 | 422 | $844,000 | $290,728 | 34.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 46 | 296 | $95,500 | $33,559 | 35.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 101 | 181 | $54,300 | $17,304 | 31.9% |
| 92134 | Imaging of retina | Office | 2023 | 137 | 488 | $48,800 | $16,624 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 91 | $22,750 | $9,621 | 42.3% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 25 | 137 | $61,650 | $8,879 | 14.4% |
| 92242 | Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | Office | 2023 | 24 | 24 | $8,400 | $5,827 | 69.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $13,600 | $4,223 | 31.1% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 97 | 181 | $9,050 | $2,122 | 23.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 20 | 296 | $592,000 | $210,138 | 35.5% |
| 67028 | Injection of drug into eye | Office | 2022 | 45 | 213 | $67,750 | $24,355 | 35.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 101 | 153 | $45,900 | $15,548 | 33.9% |
| 92134 | Imaging of retina | Office | 2022 | 159 | 426 | $42,600 | $14,788 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 80 | $20,000 | $8,694 | 43.5% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 23 | 115 | $35,250 | $8,356 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $23,200 | $7,696 | 33.2% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 24 | 24 | $8,400 | $2,719 | 32.4% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 127 | 209 | $10,450 | $2,653 | 25.4% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 12 | 15 | $750.00 | $256.47 | 34.2% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 12 | 144 | $288,000 | $105,385 | 36.6% |
| 67028 | Injection of drug into eye | Office | 2021 | 19 | 87 | $29,250 | $10,459 | 35.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 68 | 104 | $31,200 | $10,102 | 32.4% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 100 | 237 | $23,700 | $8,389 | 35.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 48 | $12,000 | $5,603 | 46.7% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 35 | 35 | $12,250 | $3,552 | 29.0% |
About Dr. Jamison Ridgeley, MD
Dr. Jamison Ridgeley, MD is a Ophthalmology healthcare provider based in Renton, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1174780530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jamison Ridgeley, MD has received a total of $912.34 in payments from pharmaceutical and medical device companies, with $29.61 received in 2024. These payments were reported across 18 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($912.34).
As a Medicare-enrolled provider, Ridgeley has provided services to 1,780 Medicare beneficiaries, totaling 4,768 services with total Medicare billing of $863,350. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Renton, WA
- Active Since 05/21/2008
- Last Updated 11/24/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1174780530
Products in Payments
- EYLEA AFLIBERCEPT INJECTION (Biological) $146.36
- Susvimo (Drug) $126.33
- LUXTURNA (Biological) $124.99
- EYLEA (Biological) $121.86
- VABYSMO (Drug) $119.03
- Iluvien (Drug) $93.68
- OZURDEX (Drug) $29.61
- Lucentis (Biological) $28.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Renton
Dr. Joseph King, Md, MD
Ophthalmology — Payments: $29,221
Ophthalmology $29,221
George Ko, Md, MD
Ophthalmology — Payments: $28,539
Ophthalmology $28,539
Dr. Kenneth Fung, M.d., M.b.a, M.D., M.B.A
Ophthalmology — Payments: $2,043
Ophthalmology $2,043
Silvia Mckevitt, Md, MD
Ophthalmology — Payments: $1,445
Ophthalmology $1,445
Dr. Samaneh Davoudimoghaddam, Md, MD
Ophthalmology — Payments: $745.90
Ophthalmology $745.90
Howard Straub, Do, DO
Ophthalmology — Payments: $729.71
Ophthalmology $729.71